![](/img/cover-not-exists.png)
A phase I study of oral uracil/ftorafur (UFT) plus leucovorin and bis-acetato-ammine-dichloro-cyclohexylamine-platinum IV (JM-216) each given over 14 days every 28 days
Mark D. DeMario, Mark J. Ratain, Nicholas J. Vogelzang, Sridhar Mani, Everett E. Vokes, Gini F. Fleming, Kimberly Melton, Sheryl Johnson, Steven Benner, David LebwohlVolume:
43
Language:
english
Pages:
4
DOI:
10.1007/s002800050911
Date:
March, 1999
File:
PDF, 72 KB
english, 1999